4//SEC Filing
SYNTA PHARMACEUTICALS CORP 4
Accession 0001179110-16-027832
$MDGLCIK 0001157601operating
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 5:22 PM ET
Size
6.5 KB
Accession
0001179110-16-027832
Insider Transaction Report
Form 4
Schneebaum Marc R
SVP and CFO
Transactions
- Award
Common Stock
2016-07-22+25,714→ 27,856 total - Tax Payment
Common Stock
2016-07-22$9.48/sh−8,548$81,035→ 19,308 total
Footnotes (3)
- [F1]Represents the vesting and settlement of restricted stock units ("RSUs") upon the completion of the Issuer's merger transaction with Madrigal Pharmaceuticals, Inc. on July 22, 2016.
- [F2]Reflects a 1-for-35 reverse stock split that was effected by the Issuer on July 22, 2016.
- [F3]Shares withheld by the Registrant to satisfy minimum statutory withholding requirements upon vesting of RSUs. Withheld shares were not sold.
Documents
Issuer
SYNTA PHARMACEUTICALS CORP
CIK 0001157601
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001157601
Filing Metadata
- Form type
- 4
- Filed
- Jul 21, 8:00 PM ET
- Accepted
- Jul 22, 5:22 PM ET
- Size
- 6.5 KB